Journal of ISAKOS is Gold Open Access

Journal of ISAKOS Advances to Open Access and Moves to Elsevier

Authors who publish in the Gold open access Journal of ISAKOS (JISAKOS) can make their research work immediately, permanently, and freely accessible worldwide.

As an open access journal, JISAKOS will ask authors whose papers are accepted for publishing to pay an article publishing charge (APC), giving authors a choice of license options plus the ability to retain copyright to their published work. Corresponding authors who are ISAKOS members are eligible for a 20% APC discount, and even non-member authors will have the ability to join ISAKOS and access the APC discount. The APC is not required upon submission but will be requested after peer review and acceptance. The APC for JISAKOS will be USD $750 for shorter articles, such as case reports, and USD $1,500 for full-length articles.

JISAKOS currently has an impact factor of 2.7 with a CiteScore of 1.8. Available on Science Direct and indexed in Medline/PUBMED as well as the Clarivate Emerging Sources Citation Index, JISAKOS is led by Editor-in-Chief Olufemi R. Ayeni MD, PhD, MSc, FRCSC from Canada. As the official journal of ISAKOS, JISAKOS synthesizes the latest research and evidence-based guidelines in orthopaedic sports medicine and traumatology-including joint disorders-to provide busy orthopaedic surgeons and specialists a thorough reference for diagnosing and treating patients.

Corresponding authors who are ISAKOS members are eligible for a 20% APC discount. Non-member corresponding authors have the ability to join ISAKOS and access the APC discount.